Literature DB >> 29760071

PRDM1 silences stem cell-related genes and inhibits proliferation of human colon tumor organoids.

Changlong Liu1, Carolyn E Banister1, Charles C Weige1, Diego Altomare1, Joseph H Richardson2, Carlo M Contreras2, Phillip J Buckhaults3.   

Abstract

PRDM1 is a tumor suppressor that plays an important role in B and T cell lymphomas. Our previous studies demonstrated that PRDM1β is a p53-response gene in human colorectal cancer cells. However, the function of PRDM1β in colorectal cancer cells and colon tumor organoids is not clear. Here we show that PRDM1β is a p53-response gene in human colon organoids and that low PRDM1 expression predicts poor survival in colon cancer patients. We engineered PRDM1 knockouts and overexpression clones in RKO cells and characterized the PRDM1-dependent transcript landscapes, revealing that both the α and β transcript isoforms repress MYC-response genes and stem cell-related genes. Finally, we show that forced expression of PRDM1 in human colon cancer organoids prevents the formation and growth of colon tumor organoids in vitro. These results suggest that p53 may exert tumor-suppressive effects in part through a PRDM1-dependent silencing of stem cell genes, depleting the size of the normal intestinal stem cell compartment in response to DNA damage.

Entities:  

Keywords:  CRISPR; PRDM1; TP53; colorectal cancer; organoids

Mesh:

Substances:

Year:  2018        PMID: 29760071      PMCID: PMC5984534          DOI: 10.1073/pnas.1802902115

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

1.  BLIMP1 regulates cell growth through repression of p53 transcription.

Authors:  Junli Yan; Jianming Jiang; Ching Aeng Lim; Qiang Wu; Huck-Hui Ng; Keh-Chuang Chin
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-30       Impact factor: 11.205

2.  Characterization of genomic deletion efficiency mediated by clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9 nuclease system in mammalian cells.

Authors:  Matthew C Canver; Daniel E Bauer; Abhishek Dass; Yvette Y Yien; Jacky Chung; Takeshi Masuda; Takahiro Maeda; Barry H Paw; Stuart H Orkin
Journal:  J Biol Chem       Date:  2014-06-06       Impact factor: 5.157

3.  Identification of a functionally impaired positive regulatory domain I binding factor 1 transcription repressor in myeloma cell lines.

Authors:  Ildikó Györy; György Fejér; Nilanjan Ghosh; Ed Seto; Kenneth L Wright
Journal:  J Immunol       Date:  2003-03-15       Impact factor: 5.422

4.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

5.  Transcriptomes and shRNA suppressors in a TP53 allele-specific model of early-onset colon cancer in African Americans.

Authors:  Charles C Weige; Marc R Birtwistle; Himel Mallick; Nengjun Yi; Zuzana Berrong; Emily Cloessner; Keely Duff; Josephine Tidwell; Megan Clendenning; Brent Wilkerson; Christopher Farrell; Fred Bunz; Hao Ji; Michael Shtutman; Kim E Creek; Carolyn E Banister; Phillip J Buckhaults
Journal:  Mol Cancer Res       Date:  2014-04-17       Impact factor: 5.852

6.  Enhanced efficiency of human pluripotent stem cell genome editing through replacing TALENs with CRISPRs.

Authors:  Qiurong Ding; Stephanie N Regan; Yulei Xia; Leoníe A Oostrom; Chad A Cowan; Kiran Musunuru
Journal:  Cell Stem Cell       Date:  2013-04-04       Impact factor: 24.633

7.  Prospective derivation of a living organoid biobank of colorectal cancer patients.

Authors:  Marc van de Wetering; Hayley E Francies; Joshua M Francis; Gergana Bounova; Francesco Iorio; Apollo Pronk; Winan van Houdt; Joost van Gorp; Amaro Taylor-Weiner; Lennart Kester; Anne McLaren-Douglas; Joyce Blokker; Sridevi Jaksani; Sina Bartfeld; Richard Volckman; Peter van Sluis; Vivian S W Li; Sara Seepo; Chandra Sekhar Pedamallu; Kristian Cibulskis; Scott L Carter; Aaron McKenna; Michael S Lawrence; Lee Lichtenstein; Chip Stewart; Jan Koster; Rogier Versteeg; Alexander van Oudenaarden; Julio Saez-Rodriguez; Robert G J Vries; Gad Getz; Lodewyk Wessels; Michael R Stratton; Ultan McDermott; Matthew Meyerson; Mathew J Garnett; Hans Clevers
Journal:  Cell       Date:  2015-05-07       Impact factor: 41.582

8.  PRDI-BF1 recruits the histone H3 methyltransferase G9a in transcriptional silencing.

Authors:  Ildikó Gyory; Jian Wu; György Fejér; Edward Seto; Kenneth L Wright
Journal:  Nat Immunol       Date:  2004-02-22       Impact factor: 25.606

9.  Targeting non-coding RNAs with the CRISPR/Cas9 system in human cell lines.

Authors:  Tsui-Ting Ho; Nanjiang Zhou; Jianguo Huang; Pratirodh Koirala; Min Xu; Roland Fung; Fangting Wu; Yin-Yuan Mo
Journal:  Nucleic Acids Res       Date:  2014-11-20       Impact factor: 16.971

10.  How many biological replicates are needed in an RNA-seq experiment and which differential expression tool should you use?

Authors:  Nicholas J Schurch; Pietá Schofield; Marek Gierliński; Christian Cole; Alexander Sherstnev; Vijender Singh; Nicola Wrobel; Karim Gharbi; Gordon G Simpson; Tom Owen-Hughes; Mark Blaxter; Geoffrey J Barton
Journal:  RNA       Date:  2016-03-28       Impact factor: 4.942

View more
  17 in total

1.  Loss of prdm1a accelerates melanoma onset and progression.

Authors:  Ritsuko Iwanaga; Brittany T Truong; Jessica Y Hsu; Karoline A Lambert; Rajesh Vyas; David Orlicky; Yiqun G Shellman; Aik-Choon Tan; Craig Ceol; Kristin Bruk Artinger
Journal:  Mol Carcinog       Date:  2020-06-20       Impact factor: 4.784

2.  MiR-223-3p promotes the proliferation, invasion and migration of colon cancer cells by negative regulating PRDM1.

Authors:  Bao Chai; Yarong Guo; Xiangli Cui; Jinchun Liu; Yuhong Suo; Zhangfeng Dou; Ning Li
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

3.  Spindle Assembly Checkpoint Inhibition Can Resensitize p53-Null Stem Cells to Cancer Chemotherapy.

Authors:  Changlong Liu; Carolyn E Banister; Phillip J Buckhaults
Journal:  Cancer Res       Date:  2019-03-12       Impact factor: 12.701

4.  Host T Cell Dedifferentiation Effects Drive HIV-1 Latency Stability.

Authors:  Alexander G Dalecki; Braxton D Greer; Alexandra Duverger; Elan L Strange; Eric Carlin; Frederic Wagner; Bi Shi; Kelsey E Lowman; Mildred Perez; Christopher Tidwell; Katarzyna Kaczmarek Michaels; Sophia Giattina; Stefan H Bossmann; Andrew J Henderson; Hui Hu; Olaf Kutsch
Journal:  J Virol       Date:  2022-01-12       Impact factor: 6.549

5.  Mucosal ribosomal stress-induced PRDM1 promotes chemoresistance via stemness regulation.

Authors:  Juil Kim; Yuseok Moon
Journal:  Commun Biol       Date:  2021-05-10

6.  Serine-threonine Kinase Receptor-Associated Protein is a Critical Mediator of APC Mutation-Induced Intestinal Tumorigenesis Through a Feed-Forward Mechanism.

Authors:  Trung Vu; Arunima Datta; Carolyn Banister; Lin Jin; Guandou Yuan; Temesgen Samuel; Sejong Bae; Isam-Eldin Eltoum; Upender Manne; Bixiang Zhang; Robert S Welner; Kasturi Mitra; Phillip Buckhaults; Pran K Datta
Journal:  Gastroenterology       Date:  2021-09-11       Impact factor: 33.883

Review 7.  CRISPR/Cas system: An emerging technology in stem cell research.

Authors:  Maria Teresa Valenti; Michela Serena; Luca Dalle Carbonare; Donato Zipeto
Journal:  World J Stem Cells       Date:  2019-11-26       Impact factor: 5.326

8.  Targeting lysyl oxidase (LOX) overcomes chemotherapy resistance in triple negative breast cancer.

Authors:  Ozge Saatci; Aysegul Kaymak; Umar Raza; Pelin G Ersan; Ozge Akbulut; Carolyn E Banister; Vitali Sikirzhytski; Unal Metin Tokat; Gamze Aykut; Suhail A Ansari; Hayriye Tatli Dogan; Mehmet Dogan; Pouria Jandaghi; Aynur Isik; Fatma Gundogdu; Kemal Kosemehmetoglu; Omer Dizdar; Sercan Aksoy; Aytekin Akyol; Aysegul Uner; Phillip J Buckhaults; Yasser Riazalhosseini; Ozgur Sahin
Journal:  Nat Commun       Date:  2020-05-15       Impact factor: 14.919

Review 9.  Multifaceted Role of PRDM Proteins in Human Cancer.

Authors:  Amelia Casamassimi; Monica Rienzo; Erika Di Zazzo; Anna Sorrentino; Donatella Fiore; Maria Chiara Proto; Bruno Moncharmont; Patrizia Gazzerro; Maurizio Bifulco; Ciro Abbondanza
Journal:  Int J Mol Sci       Date:  2020-04-10       Impact factor: 5.923

10.  Differential epigenetic regulation between the alternative promoters, PRDM1α and PRDM1β, of the tumour suppressor gene PRDM1 in human multiple myeloma cells.

Authors:  Raquel Romero-García; Laura Gómez-Jaramillo; Rosa María Mateos; Gema Jiménez-Gómez; Nuria Pedreño-Horrillo; Esther Foncubierta; Juan Francisco Rodríguez-Gutiérrez; Sebastián Garzón; Francisco Mora-López; Carmen Rodríguez; Luis M Valor; Antonio Campos-Caro
Journal:  Sci Rep       Date:  2020-09-28       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.